Noida is set to strengthen its position as a major healthcare manufacturing hub as world-class medical device testing laboratories are planned at the upcoming Medical Device Park in Sector 28. The move is expected to significantly enhance India’s ability to produce and certify medical equipment to global standards without relying on overseas facilities.
The Yamuna Expressway Industrial Development Authority (YEIDA) has partnered with Ahmedabad-based Accuprec Research Labs to establish advanced testing centres aligned with internationally recognised norms. These laboratories will follow standards under the US Food and Drug Administration’s ASCA (Accreditation Scheme for Conformity Assessment) programme, enabling devices manufactured in the park to meet strict global regulatory requirements.
Faster Certification, Lower Costs for Manufacturers
Currently, many Indian medical device manufacturers must send products abroad for specialised testing and certification — a process that is expensive and time-consuming. Once operational, the new labs will allow companies to complete these procedures locally, reducing costs and speeding up market entry.
Officials say the facility will support testing across multiple product categories, ensuring manufacturers can design, develop and validate devices within a single integrated ecosystem.
Strategic Push for Export Growth
The project is also aimed at boosting India’s medical device exports, a sector witnessing rapid growth worldwide. With certification infrastructure available domestically, companies operating in the park will be better positioned to compete in international markets, particularly in the United States and Europe.
Industry experts believe the initiative could attract global manufacturers, research organisations and startups to invest in the region, transforming the area into a major med-tech cluster.
Two-Phase Investment Plan
Accuprec has proposed a two-part development strategy. The first phase involves upgrading existing scientific facilities to meet ASCA requirements and other regulatory standards. The second phase will add new testing modules for device categories not covered under current infrastructure.
Technical teams have already inspected the site and assessed how laboratory systems can be integrated with utilities, engineering networks and safety protocols.
Toward a Complete Medical Device Ecosystem
Authorities say the inclusion of internationally certified testing labs will make the Noida Medical Device Park one of the few facilities in India offering end-to-end capabilities — from manufacturing to quality validation under one roof.
A detailed technical feasibility report is expected within a month, after which the project timeline will be finalised. If executed as planned, the initiative could mark a major milestone in India’s journey toward becoming a global manufacturing and innovation hub for medical technology.
